Eslicarbazepine

Aptiom

NADAC/unit $3.0461

No Shortage Tier 1: 88.8% PA Req: 64.4% 8 Manufacturers 32 ANDAs

Eslicarbazepine acetate tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older.

vs. brand Aptiom: Generic saves up to 70% per unit

Covered Lives

Generic Manufacturers

ALKEM LABORATORIES LTDAPOTEX INCDR REDDYS LABORATORIES LTDHETERO LABS LTD UNIT VJUBILANT GENERICS LTDLUPIN LTDSPH ZHONGXI PHARMACEUTICAL CO LTDSUMITOMO PHARMA AMERICA INCTORRENT PHARMACEUTICALS LTD

Explore in the Ecosystem

rxsaver.aiCompare prices for Eslicarbazepine drfinder.aiFind doctors who prescribe Eslicarbazepine rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Eslicarbazepine

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.